Defense Department Applies AI Chatbots in Military Medicine Pilot

Chief Digital and Artificial Intelligence Office provides the latest report. The Department of Defense reported that its artificial intelligence (AI) office successfully concluded a pilot program that tested…

Read More

Federal Court Rules in Favor of Generic Drug Competition in Patent Case

The court orders the removal of improper patent listings, clearing the path for lower-cost medications. The Federal Circuit U.S. Court of Appeals recently upheld a lower court’s decision…

Read More

FDA Approves Medication for Rare Adrenal Gland Disorder

Crenessity reduces glucocorticoid dependency and improves hormone control for classic CAH. The FDA has recently approved Crenessity (crinecerfont) for use alongside glucocorticoids in treating adults and children aged…

Read More

Medicare Proposal Expands Access to Care and Consumer Protections

CMS seeks to enhance Medicare Advantage and Part D programs, including coverage for anti-obesity medications. The Centers for Medicare and Medicaid Services (CMS) recently proposed updates to Medicare…

Read More

Efforts Underway to Restore IV Fluid Supply in Hurricane Disruption of NC Facility

Federal agencies and Baxter International collaborate to boost IV fluid availability following severe storm damage. Hurricane Helene caused damage to Baxter International’s North Cove facility in North Carolina,…

Read More

Supreme Court Declines Appeal by Former Pharma Executive

The court upholds the $64 million penalty, holding the former CEO liable for price gouging and fraud. The Supreme Court declined to hear an appeal filed by former…

Read More

FDA Approves New Schizophrenia Treatment with a Breakthrough Mechanism

Cobenfy offers an alternative that addresses symptoms of schizophrenia with a different approach. The U.S. Food and Drug Administration (FDA) recently approved Cobenfy (xanomeline and trospium chloride) for…

Read More

Medicare Announces Maximum Drug Prices After Negotiations

HHS secretary states that the negotiations will save Americans $3.7 billion in the first year. Medicare announced its first finalized list of drug price maximums for 10 prescription…

Read More

HHS Announces Funding for HIV Medication Assistance

$1.4 billion allotted to help 560,000 patients afford life-saving drug. The Department of Health and Human Services (HHS) announced over $1.4 billion has been allocated to HIV medication…

Read More

FDA Approves First TCR Gene Therapy for Synovial Sarcoma

Tecelra treats rare cancer through immunotherapy. The U.S. Food and Drug Administration (FDA) has approved Tecelra (afamitresgene autoleucel), a gene therapy for adults with unresectable or metastatic synovial…

Read More

Back to top
FE3